4-butyrolactone has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, T; Chigira, M; Dobashi, Y; Kameya, T; Kitagawa, M; Shoji, M; Tamauchi, H; Wakata, Y | 1 |
| Akiyama, T; Nakajima, M; Okuyama, A | 1 |
1 review(s) available for 4-butyrolactone and Fibrosarcoma
| Article | Year |
|---|---|
[CDK and MMP inhibitors].
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Colonic Neoplasms; Cyclin-Dependent Kinases; Dipeptides; Doxorubicin; Enzyme Inhibitors; Fibrosarcoma; Humans; Metalloendopeptidases; Mice; Mice, Nude; Protease Inhibitors; Succinates | 1997 |
1 other study(ies) available for 4-butyrolactone and Fibrosarcoma
| Article | Year |
|---|---|
Cell cycle control with minimal participation of Cdk2 in a murine fibrosarcoma clone cultured in protein-free medium.
Topics: 4-Butyrolactone; Animals; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cell Separation; Culture Media, Serum-Free; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Fibrosarcoma; Flow Cytometry; Mice; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Tumor Cells, Cultured | 1997 |